Research Article

Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up

Volume: 4 Number: 3 December 25, 2021

Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up

Abstract

Objective: To determine the risk factors for recurrence in endoscopically treated frontoethmoid mucoceles. Methods: A retrospective study was designed. The patients with frontoethmoidal mucoceles who underwent endonasal surgical approach and followed up for a minimum of 4 years were included. The demographic data of patients, symptoms, etiological and prognostic features, location, and classification of the mucocele were recorded. Results: Sixty-four patients were included in the study. The mean age of patients was 45.2 [range: 10-83, standard deviation (SD):618.2], and the male: female ratio was 0.72. The mean follow-up duration was 75 months (min. 52, max. 168 months, SD: 42.1). Bone erosion at lamina papyracea was detected in 30 patients (46.9%), orbital roof (n¼ 20, 31.3%), and ethmoid roof (n¼ 15, 23.4%). Major complications were encountered in two patients (% 8). During follow-up (mean: 75 months min. 52, max. 168, SD: 42.1), recurrence was found in eight cases (12.5%). Comparison of risk factors regarding recurrence of mucocele after surgery showed statistical significance for posterior frontal wall dehiscence (P¼ .014) and revision endoscopic surgery (P¼ .005). However, further analysis with binary logistic regression, revision nasal endoscopic sinus surgery was the only significant risk factor for mucocele recurrence (P¼ .047, odds ratio: 6.43). Conclusion: Endoscopic endonasal marsupialization of frontoethmoid mucoceles is a safe and efficient for management. A long-term follow-up is important for the accurate assessment of recurrence. The presence of revision nasal surgery was a significant risk factor for recurrence, so, more extensive surgeries can be considered to minimize the risk.

Keywords

References

  1. Stiernberg CM, Bailey BJ, Calhoun KH, Quinn FB. Management of invasive frontoethmoidal sinus mucoceles. Arch Otolaryngol Head Neck Surg. 1986;112(10):1060-1063.
  2. Herndon M, McMains KC, Kountakis SE. Presentation and management of extensive fronto-orbital-ethmoid mucoceles. Am J Otolaryngol. 2007;28(3):145-147.
  3. Nazar R, Naser A, Pardo J, Fulla J, Rodrı´guez-Jorge J, Delano PH. Manejo endoscópico de mucoceles de senos paranasales: Experiencia en 46 pacientes [Endoscopic management of paranasal sinus mucoceles: Experience with 46 patients]. Acta Otorrinolaringol Esp. 2011;62(5):363-366.
  4. Sautter NB, Citardi MJ, Perry J, Batra PS. Paranasal sinus mucoceles with skullbase and/or orbital erosion: Is the endoscopic approach sufficient? Otolaryngol Head Neck Surg. 2008;139(4):570-574.
  5. Conboy PJ, Jones NS. The place of endoscopic sinus surgery in the treatment of paranasal sinus mucocoeles. Clin Otolaryngol. 2003;28(3):207-210.
  6. Scangas GA, Gudis DA, Kennedy DW. The natural history and clinical characteristics of paranasal sinus mucoceles: A clinical review. Int Forum Allergy Rhinol. 2013;3(9):712-717.
  7. Obeso S, Llorente JL, Pablo Rodrigo J, Sa´nchez R, Mancebo G, Sua´rez C. Mucoceles de senos paranasales. Nuestra experiencia en 72 pacientes [Paranasal sinuses mucoceles. Our experience in 72 patients]. Acta Otorrinolaringol Esp. 2009;60(5):332-339.
  8. Khong JJ, Malhotra R, Selva D, Wormald PJ. Efficacy of endoscopic sinus surgery for paranasal sinus mucocele including modified endoscopic Lothrop procedure for frontal sinus mucocele. J Laryngol Otol. 2004;118(5):352-356.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Research Article

Publication Date

December 25, 2021

Submission Date

October 6, 2021

Acceptance Date

November 16, 2021

Published in Issue

Year 2021 Volume: 4 Number: 3

APA
Eren, E., İşlek, A., Demir, U. L., Göde, S., & Karcı, H. (2021). Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. European Journal of Rhinology and Allergy, 4(3), 81-86. https://doi.org/10.5152/ejra.2021.21046
AMA
1.Eren E, İşlek A, Demir UL, Göde S, Karcı H. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. 2021;4(3):81-86. doi:10.5152/ejra.2021.21046
Chicago
Eren, Erdem, Akif İşlek, Uygar Levent Demir, Sercan Göde, and Halil Karcı. 2021. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy 4 (3): 81-86. https://doi.org/10.5152/ejra.2021.21046.
EndNote
Eren E, İşlek A, Demir UL, Göde S, Karcı H (December 1, 2021) Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. European Journal of Rhinology and Allergy 4 3 81–86.
IEEE
[1]E. Eren, A. İşlek, U. L. Demir, S. Göde, and H. Karcı, “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up”, Eur J Rhinol Allergy, vol. 4, no. 3, pp. 81–86, Dec. 2021, doi: 10.5152/ejra.2021.21046.
ISNAD
Eren, Erdem - İşlek, Akif - Demir, Uygar Levent - Göde, Sercan - Karcı, Halil. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy 4/3 (December 1, 2021): 81-86. https://doi.org/10.5152/ejra.2021.21046.
JAMA
1.Eren E, İşlek A, Demir UL, Göde S, Karcı H. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. 2021;4:81–86.
MLA
Eren, Erdem, et al. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy, vol. 4, no. 3, Dec. 2021, pp. 81-86, doi:10.5152/ejra.2021.21046.
Vancouver
1.Erdem Eren, Akif İşlek, Uygar Levent Demir, Sercan Göde, Halil Karcı. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. 2021 Dec. 1;4(3):81-6. doi:10.5152/ejra.2021.21046

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.